A Rollover Study to Provide Chronic T-1249 to Patients Who Completed Study T1249-102
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00048217|
Recruitment Status : Unknown
Verified July 2004 by Trimeris.
Recruitment status was: Active, not recruiting
First Posted : October 30, 2002
Last Update Posted : June 24, 2005
|Condition or disease||Intervention/treatment||Phase|
|HIV Infections||Drug: T-1249||Phase 1 Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Masking:||None (Open Label)|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00048217
|United States, North Carolina|
|Durham, North Carolina, United States, 27707|